エピソード

  • JACC: CardioOncology - JACC: CardioOncology - February 2025 Issue Summary

    JACC: CardioOncology - JACC: CardioOncology - February 2025 Issue Summary
    2025/02/18
    2 分
  • JACC: CardioOncology - SGLT2i Therapy Prevents Anthracycline-Induced Cardiotoxicity in a Large Animal Model by Preserving Myocardial Energetics

    JACC: CardioOncology - SGLT2i Therapy Prevents Anthracycline-Induced Cardiotoxicity in a Large Animal Model by Preserving Myocardial Energetics
    2025/02/18

    Commentary by Dr. Ali Javaheri
    続きを読む 一部表示
    4 分
  • JACC: CardioOncology - The Association of Malignancy with Stroke and Bleeding in Atrial Fibrillation: A Population-Based Cohort Study

    JACC: CardioOncology - The Association of Malignancy with Stroke and Bleeding in Atrial Fibrillation: A Population-Based Cohort Study
    2025/02/18

    Commentary by Dr. Lorenzo Gervaso
    続きを読む 一部表示
    3 分
  • JACC: CardioOncology - Growth Differentiation Factor-15 Predicts Major Bleeding in Cancer Patients: Results from the Vienna CAT-BLED Study

    JACC: CardioOncology - Growth Differentiation Factor-15 Predicts Major Bleeding in Cancer Patients: Results from the Vienna CAT-BLED Study
    2025/02/18

    Commentary by Dr. Vivek Narayan
    続きを読む 一部表示
    5 分
  • JACC: CardioOncology - Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline- Based Chemotherapy

    JACC: CardioOncology - Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline- Based Chemotherapy
    2025/02/18

    Commentary by Dr. Giselle Melendez
    続きを読む 一部表示
    4 分
  • JACC: CardioOncology - Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy

    JACC: CardioOncology - Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy
    2025/02/18

    Commentary by Dr. Mina Sedrak
    続きを読む 一部表示
    4 分
  • JACC: CardioOncology - Effects of Systemic Anticancer Treatment on Cardiorespiratory Fitness: A Systematic Review and Meta-Analysis

    JACC: CardioOncology - Effects of Systemic Anticancer Treatment on Cardiorespiratory Fitness: A Systematic Review and Meta-Analysis
    2025/02/18

    Commentary by Dr. Erin Howden
    続きを読む 一部表示
    3 分
  • Revisiting ICD Therapy for Primary Prevention in Patients With Heart Failure and Reduced Ejection Fraction

    Revisiting ICD Therapy for Primary Prevention in Patients With Heart Failure and Reduced Ejection Fraction
    2025/02/17

    Dr. Valentin Fuster discusses the February 2025 issue of JACC, which focuses on advancements in heart failure research. The discussion covers five key sections: heart failure with preserved ejection fraction, hypertrophic cardiomyopathy, cardiac amyloidosis, standardization of kidney function, and ICD therapy for primary prevention in heart failure patients. Experts explore emerging therapies, diagnostic thresholds, and the potential impact of blood pressure and genetics on patient outcomes, underscoring the need for comprehensive approaches in managing these complex conditions.
    続きを読む 一部表示
    1 時間 2 分